GL1X · GenesisL1 explorer

Research workbench

Structure-based drug design of novel aurora kinase a inhibitors: structure basis for potency and specificity

Analyse Structure-based drug design of novel aurora kinase a inhibitors: structure… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3FDN
Type
protein
Length
261 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SERINE/THREONINE-protein kinase 6
EC
2.7.11.1
UniProt
O14965
Ligands
MMH
Pockets
3 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASERINE/THREONINE-protein kinase 6 (EC 2.7.11.1)protein26140% helix, 19% strandO14965

Ligands and binding sites

  • MMH · N-[3-(acetylamino)phenyl]-5-{(2E)-2-[(4-methoxyphenyl)methylidene]hydrazino}-3-methyl-1H-pyrazole-4-carboxamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15660.710.7944MMH
2760.410.7913empty
3530.390.8116empty

Compared structures

  • 3FDN · Structure-based drug design of novel Aurora kinase A inhibitors: Structure basis for… · the same entry in another collection · chain A against A, TM-score 1.00
  • O14965 · AlphaFold monomer V2.0 prediction for aurora kinase a (O14965) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.